134 related articles for article (PubMed ID: 11211609)
1. PS6K amplification characterizes a small subset of anaplastic meningiomas.
Cai DX; James CD; Scheithauer BW; Couch FJ; Perry A
Am J Clin Pathol; 2001 Feb; 115(2):213-8. PubMed ID: 11211609
[TBL] [Abstract][Full Text] [Related]
2. Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer.
Couch FJ; Wang XY; Wu GJ; Qian J; Jenkins RB; James CD
Cancer Res; 1999 Apr; 59(7):1408-11. PubMed ID: 10197603
[TBL] [Abstract][Full Text] [Related]
3. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of HER2 expression in meningiomas: an immunohistochemical and fluorescence in situ hybridization study.
Loussouarn D; Brunon J; Avet-Loiseau H; Campone M; Mosnier JF
Hum Pathol; 2006 Apr; 37(4):415-21. PubMed ID: 16564915
[TBL] [Abstract][Full Text] [Related]
5. Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization.
Ishino S; Hashimoto N; Fushiki S; Date K; Mori T; Fujimoto M; Nakagawa Y; Ueda S; Abe T; Inazawa J
Cancer; 1998 Jul; 83(2):360-6. PubMed ID: 9669820
[TBL] [Abstract][Full Text] [Related]
6. 17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGma1B genes.
Wu GJ; Sinclair CS; Paape J; Ingle JN; Roche PC; James CD; Couch FJ
Cancer Res; 2000 Oct; 60(19):5371-5. PubMed ID: 11034073
[TBL] [Abstract][Full Text] [Related]
7. Functional significance of S6K overexpression in meningioma progression.
Surace EI; Lusis E; Haipek CA; Gutmann DH
Ann Neurol; 2004 Aug; 56(2):295-8. PubMed ID: 15293284
[TBL] [Abstract][Full Text] [Related]
8. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma.
Lusis EA; Watson MA; Chicoine MR; Lyman M; Roerig P; Reifenberger G; Gutmann DH; Perry A
Cancer Res; 2005 Aug; 65(16):7121-6. PubMed ID: 16103061
[TBL] [Abstract][Full Text] [Related]
9. Allelic gain and amplification on the long arm of chromosome 17 in anaplastic meningiomas.
Büschges R; Ichimura K; Weber RG; Reifenberger G; Collins VP
Brain Pathol; 2002 Apr; 12(2):145-53. PubMed ID: 11958368
[TBL] [Abstract][Full Text] [Related]
10. Her-2/neu gene amplification in paraffin-embedded tissue sections of meningioma patients.
Ozer O; Sahin FI; Aydemir F; Ozen O; Yilmaz Z; Altinörs N
Turk Neurosurg; 2009 Apr; 19(2):135-8. PubMed ID: 19431122
[TBL] [Abstract][Full Text] [Related]
11. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes.
Holzmann K; Kohlhammer H; Schwaenen C; Wessendorf S; Kestler HA; Schwoerer A; Rau B; Radlwimmer B; Döhner H; Lichter P; Gress T; Bentz M
Cancer Res; 2004 Jul; 64(13):4428-33. PubMed ID: 15231651
[TBL] [Abstract][Full Text] [Related]
12. Correlation of DNA content and nucleomorphometric features with World Health Organization grading of meningiomas.
Grunewald JP; Röhl FW; Kirches E; Dietzmann K
Mod Pathol; 1998 Feb; 11(2):216-23. PubMed ID: 9504694
[TBL] [Abstract][Full Text] [Related]
13. Bcl2 and ROS1 expression in human meningiomas: an analysis with respect to histological subtype.
Girish V; Sachdeva N; Minz RW; Radotra B; Mathuria SN; Arora SK
Indian J Pathol Microbiol; 2005 Jul; 48(3):325-30. PubMed ID: 16761743
[TBL] [Abstract][Full Text] [Related]
14. [The molecular genetics of meningiomas and genotypic/phenotypic correlations].
Dezamis E; Sanson M
Rev Neurol (Paris); 2003 Sep; 159(8-9):727-38. PubMed ID: 13679715
[TBL] [Abstract][Full Text] [Related]
15. Microarray-based analysis of spinal versus intracranial meningiomas: different clinical, biological, and genetic characteristics associated with distinct patterns of gene expression.
Sayagués JM; Tabernero MD; Maíllo A; Trelles O; Espinosa AB; Sarasquete ME; Merino M; Rasillo A; Vera JF; Santos-Briz A; de Alava E; Garcia-Macias MC; Orfao A
J Neuropathol Exp Neurol; 2006 May; 65(5):445-54. PubMed ID: 16772868
[TBL] [Abstract][Full Text] [Related]
16. Comparative proteomic profiles of meningioma subtypes.
Okamoto H; Li J; Vortmeyer AO; Jaffe H; Lee YS; Gläsker S; Sohn TS; Zeng W; Ikejiri B; Proescholdt MA; Mayer C; Weil RJ; Oldfield EH; Zhuang Z
Cancer Res; 2006 Oct; 66(20):10199-204. PubMed ID: 17047085
[TBL] [Abstract][Full Text] [Related]
17. [Meningiomas: new prognostic factors].
Sanz Esponera J
An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
[TBL] [Abstract][Full Text] [Related]
18. Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival.
Mihaila D; Jankowski M; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
Clin Cancer Res; 2003 Oct; 9(12):4443-51. PubMed ID: 14555517
[TBL] [Abstract][Full Text] [Related]
19. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic subclassification of meningiomas based on genome-wide DNA methylation analyses.
Kishida Y; Natsume A; Kondo Y; Takeuchi I; An B; Okamoto Y; Shinjo K; Saito K; Ando H; Ohka F; Sekido Y; Wakabayashi T
Carcinogenesis; 2012 Feb; 33(2):436-41. PubMed ID: 22102699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
